Efficacy of Initiating Tobacco Dependence Treatment in Inpatient Psychiatry: A Randomized Controlled Trial

Prochaska, Judith J.; Hall, Stephen E.; Delucchi, Kevin; Hall, Sharon M.

doi:10.2105/ajph.2013.301403

Cited by 130 publications

(226 citation statements)

References 50 publications

(44 reference statements)

Supporting

Mentioning

211

Contrasting

Unclassified

Order By: Relevance

“…67,98 In addition to pharmacological treatment, other behavioral interventions (e.g., motivational interviewing and cognitive behavioral therapy) appear promising for this vulnerable population. [99][100][101] Take home point: Treat smokers with SMI with medications and/or groups.…”

Section: Clinical and Policy Implicationsmentioning

confidence: 99%

Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review

et al. 2016

View full text Add to dashboard Cite

Close to 19 million US adults have severe mental illnesses (SMI), and they die, on average, 25 years earlier than the general population, most often from cardiovascular disease (CVD). Many of the antipsychotic medications used to treat SMI contribute to CVD risk by increasing risk for obesity, type 2 diabetes, dyslipidemia, and hypertension. Based on compelling evidence, the American Diabetes Association and the American Psychiatric Association developed guidelines for metabolic screening and monitoring during use of these medications. In this manuscript, we have reviewed the evidence on diabetes and other CVD risk screening, prevalence, and management among populations with SMI. We also review differences in screening among subpopulations with SMI (e.g., racial/ethnic minorities, women, and children). We found that despite national guidelines for screening for diabetes and other cardiovascular risk factors, up to 70 % of people taking antipsychotics remain unscreened and untreated. Based on estimates that 20 % of the 19 million US adults with SMI have diabetes and 70 % of them are not screened; it is likely that over 2 million Americans with SMI have unidentified diabetes. Given that undiagnosed diabetes costs over $4,000 per person, this failure to identify diabetes among people with SMI represents a missed opportunity to prevent morbidity and translates to over $8 billion in annual preventable costs to our healthcare system. Given the high burden of disease and significant evidence of suboptimal medical care received by people with SMI, we propose several clinical and policy recommendations to improve diabetes and other CVD risk screening and care for this highly vulnerable population. These recommendations include reducing antipsychotic medication dose or switching antipsychotic medications, enhancing smoking cessation efforts, sharing electronic health records between physical and mental health care systems, and promoting integration of care.KEY WORDS: mental illness; diabetes; integration of care.

show abstract

Section: Clinical and Policy Implicationsmentioning

confidence: 99%

Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Despite evidence of the benefits of supporting the smoking cessation efforts of people with serious mental illness during hospital stays and beyond, quit rates are low and recurrence is high. Understanding the potential reasons for this situation is essential to improving the effectiveness of smoking cessation programs in psychiatric settings 20 .…”

Section: Introductionmentioning

confidence: 99%

Cigarette smoking among psychiatric patients in Brazil

et al. 2014

View full text Add to dashboard Cite

show abstract

“…In one longitudinal study, patients hospitalized on an acute psychiatric unit who received motivational cessation treatment and nicotine replacement therapy were more likely to quit successfully and less likely to be rehospitalized than were patients in the usual care group (Prochaska, Hall, Delucchi, & Hall, 2014). In a separate study, 14 (14.4%) of 137 veterans who participated in a tobacco cessation group as part of a broader substance abuse treatment program were abstinent at the 1-month follow-up (Vest et al, 2014).…”

Section: States Department Of Health and Human Services [Usdhhs] 201mentioning

confidence: 99%

Working Together to Combat Tobacco Use

Schwindt

Hudmon

2015

Archives of Psychiatric Nursing

View full text Add to dashboard Cite

Efficacy of Initiating Tobacco Dependence Treatment in Inpatient Psychiatry: A Randomized Controlled Trial

Cited by 130 publications

References 50 publications

Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review

Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review

Cigarette smoking among psychiatric patients in Brazil

Working Together to Combat Tobacco Use

Contact Info

Product

Resources

About